Components:
Medically reviewed by Fedorchenko Olga Valeryevna, PharmD. Last updated on 23.04.2022
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Top 20 medicines with the same components:
Intramuscular
Where oral therapy is not feasible, injectable corticosteroid therapy, including Kanolone Dental Paste injectable suspension is indicated for intramuscular use as follows:
Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions.
Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome).
Endocrine disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis.
Gastrointestinal diseases: To tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis.
Hematologic disorders: Acquired (autoimmune) hemolytic anemia, Diamond-Blackfan anemia, pure red cell aplasia, selected cases of secondary thrombocytopenia.
Miscellaneous: Trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy.
Neoplastic diseases: For the palliative management of leukemias and lymphomas.
Nervous system: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy.
Ophthalmic diseases: Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids.
Renal diseases: To induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus.
Respiratory diseases: Berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis.
Rheumatic disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis; acute rheumatic carditis; ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, polymyositis and systemic lupus erythematosus.
Intra-Articular
The intra-articular or soft tissue administration of Kanolone Dental Paste injectable suspension is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis of osteoarthritis.
Temporarily relieving symptoms associated with inflammation, ulcers, and lesions in the mouth caused by injury to the skin. It may also be used for other conditions as determined by your doctor.
Kanolone Dental Paste is a topical adrenocortical steroid. It works by reducing skin inflammation (redness, swelling, itching, and irritation) in a way that is not clearly understood.
Adults and Adolescents 12 Years of Age and Older
Children 2 to 12 Years of Age
Administration Information
Use Kanolone Dental Paste as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Apply Kanolone Dental Paste at bedtime unless directed otherwise by your doctor. If you are using Kanolone Dental Paste several times per day, apply it after meals unless otherwise directed by your doctor.
- Wash your hands before and after applying Kanolone Dental Paste.
- Press a small dab (about ¼ inch) to the affected area of the mouth or gums until a thin film develops. A larger amount may be needed to cover some areas. Do not rub in.
- If you miss a dose of Kanolone Dental Paste, apply it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not apply 2 doses at once.
Ask your health care provider any questions you may have about how to use Kanolone Dental Paste.
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.This medication is used in a variety of conditions such as allergic disorders, arthritis, blood diseases, breathing problems, certain cancers, eye diseases, intestinal disorders, collagen and skin diseases. Talk to your doctor about the risks and benefits of triamcinolone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use.
Kanolone Dental Paste is known as a corticosteroid hormone (glucocorticoid). It works by decreasing your body's immune response to these diseases and reduces symptoms such as swelling.
How to use Kanolone Dental Paste injection
This medication may be given by injecting into different locations such as a muscle (intramuscularly), a skin lesion (intradermally), or a joint (intra-articularly). Injections are usually given by a trained healthcare professional. If you are giving yourself intramuscular injection, you will be taught by your healthcare professional on how to properly use this medication. If any of the information is unclear, consult your healthcare professional.
The injection site, schedule, dosage, and length of treatment are based on your medical condition and response to treatment. Do not inject this medication into a vein (intravenously) or into the spine (epidurally). This medication is not recommended for injection around/into the eye or certain parts of the nose due to the risk for blindness or damage to the eye(s). Consult your doctor for more details.
Use this medication and follow the dosing schedule exactly as directed by your doctor in order to get the most benefit from it. Do not change your dose or use this medication for a longer time than prescribed. Be sure to ask your doctor or pharmacist if you have any questions about your treatment.
Wash hands with soap and water before using this medication. Before using, check this product visually for clumpy particles or discoloration. If either is present, do not use the liquid.
Before injecting each dose intramuscularly, clean the injection site with rubbing alcohol. It is important to change the location of the injection site to avoid discomfort or problem areas. Your dose may need to be gradually decreased to reduce symptoms such as weakness, weight loss, nausea, and extreme fatigue.
Shake vial before use to evenly disperse the suspension. Inject the prescribed dose immediately after withdrawing it into the syringe to avoid settling of the medication in the syringe.
Learn how to store and discard syringes, needles, and medical supplies safely. Consult your pharmacist for more information.
If you have been using this medication for a long time, do not suddenly stop it without your doctor's approval. Some conditions may become worse when this drug is suddenly stopped.
This medication may be injected into a joint to treat conditions such as arthritis and bursitis. If you have received an injection into a joint, be careful how much stress you put on that joint, even if it is feeling better. Ask your doctor how much you can move the joint while it is healing.
Inform your doctor if your condition worsens or if you have new symptoms.
See also:
What other drugs will affect Kanolone Dental Paste?
Aminoglutethimide: Aminoglutethimide may lead to a loss of corticosteroid-induced adrenal suppression.
Amphotericin B injection and potassium-depleting agents: When corticosteroids are administered concomitantly with potassium-depleting agents (ie, amphotericin B, diuretics), patients should be observed closely for development of hypokalemia. There have been cases reported in which concomitant use of amphotericin B and hydrocortisone was followed by cardiac enlargement and congestive heart failure.
Antibiotics: Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance.
Anticholinesterases: Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis. If possible, anticholinesterase agents should be withdrawn at least 24 hours before initiating corticosteroid therapy.
Anticoagulants, oral: Coadministration of corticosteroids and warfarin usually results in inhibition of response to warfarin, although there have been some conflicting reports. Therefore, coagulation indices should be monitored frequently to maintain the desired anticoagulant effect.
Antidiabetics: Because corticosteroids may increase blood glucose concentrations, dosage adjustments of antidiabetic agents may be required.
Antitubercular drugs: Serum concentrations of isoniazid may be decreased.
Cholestyramine: Cholestyramine may increase the clearance of corticosteroids.
Cyclosporine: Increased activity of both cyclosporine and corticosteroids may occur when the two are used concurrently. Convulsions have been reported with this concurrent use.
Digitalis glycosides: Patients on digitalis glycosides may be at increased risk of arrhythmias due to hypokalemia.
Estrogens, including oral contraceptives: Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect.
Hepatic enzyme inducers (eg, barbiturates, phenytoin, carbamazepine, rifampin): Drugs which induce hepatic microsomal drug metabolizing enzyme activity may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.
Ketoconazole: Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60%, leading to an increased risk of corticosteroid side effects.
Nonsteroidal anti-inflammatory drugs (NSAIDs): Concomitant use of aspirin (or other nonsteroidal anti-inflammatory drugs) and corticosteroids increases the risk of gastrointestinal side effects. Aspirin should be used cautiously in conjunction with corticosteroids in hypoprothrombinemia. The clearance of salicylates may be increased with concurrent use of corticosteroids.
Skin tests: Corticosteroids may suppress reactions to skin tests.
Vaccines: Patients on prolonged corticosteroid therapy may exhibit a diminished response to toxoids and live or inactivated vaccines due to inhibition of antibody response. Corticosteroids may also potentiate the replication of some organisms contained in live attenuated vaccines. Routine administration of vaccines or toxoids should be deferred until corticosteroid therapy is discontinued if possible.
See also:
What are the possible side effects of Kanolone Dental Paste?
In adequate, well-controlled and uncontrolled studies, 1187 patients have received Kanolone Dental Paste solution. The adverse reactions summarized below, are based upon seven placebo controlled clinical trials of 2-6 weeks duration in 847 patients with seasonal or perennial allergic rhinitis (504 patients received 200 mcg or 400 mcg per day of Kanolone Dental Paste solution and 343 patients received vehicle placebo). Adverse events reported by 2% or more of patients (regardless of relationship to treatment) who received Kanolone Dental Paste solution 200 or 400 mcg once daily and that were more common with Kanolone Dental Paste solution than with placebo are displayed in the table below. Overall, the incidence and nature of adverse events with Kanolone Dental Paste solution 400 mcg was comparable to that seen with Kanolone Dental Paste solution 200 mcg and with vehicle placebo.
Adverse events reported by 2% or more of patients who received Kanolone Dental Paste solution 200 or 400 mcg once daily and that were more common with placebo than with Kanolone Dental Paste solution included: application site reaction (e.g. transient nasal burning and stinging), rhinitis, dysmenorrhea, pain (unspecified) and allergic reaction.
The adverse effects related to the irritation of nasal mucous membranes (i.e. application site reaction) did not usually interfere with treatment. In the controlled and uncontrolled studies, approximately 0.3% of patients discontinued because of irritation of nasal mucous membranes.
Each actuation delivers Kanolone Dental Paste 55 mcg from the nasal actuator after an initial priming of 5 sprays. It will remain adequately primed for 2 weeks. If Kanolone Dental Paste is not used for >2 weeks, then it can be adequately reprimed with 1 spray. The contents of one 6.5-g bottle provide 30 actuations, and the contents of one 16.5-g bottle provide 120 actuations. After either 30 or 120 actuations, the amount of Kanolone Dental Paste delivered per actuation may not be consistent and the unit should be discarded. Each 30- and 120-actuation bottle contains Triamcinolone acetonide 3.575 and 9.075 mg, respectively.
Kanolone Dental Paste also contains the following excipients: Microcrystalline cellulose, carboxymethylcellulose sodium, polysorbate 80, dextrose, benzalkonium chloride and disodium edetate; hydrochloric acid or sodium hydroxide may be added to adjust the pH to a target of 5 within a range of 4.5 and 6.
Kanolone Dental Paste is an unscented, thixotropic, water-based metered-dose pump spray formulation unit containing a microcrystalline suspension of Kanolone Dental Paste in an aqueous medium.
Kanolone Dental Paste is a nonchlorofluorocarbon (non-CFC)-containing metered-dose pump spray.
Kanolone Dental Paste is 9-fluoro-11β,16α,17, 21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone (C24H31FO6). It has a molecular weight of 434.51.
However, we will provide data for each active ingredient